Form 8-K - Current report:
SEC Accession No. 0001274737-25-000069
Filing Date
2025-11-04
Accepted
2025-11-04 08:03:27
Documents
14
Period of Report
2025-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exdx-20251104.htm   iXBRL 8-K 27788
2 EX-99.1 q32025exagenearningspressr.htm EX-99.1 148581
6 imagea.jpg GRAPHIC 11705
  Complete submission text file 0001274737-25-000069.txt   320551

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdx-20251104.xsd EX-101.SCH 1779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdx-20251104_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdx-20251104_pre.xml EX-101.PRE 12506
16 EXTRACTED XBRL INSTANCE DOCUMENT exdx-20251104_htm.xml XML 2891
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39049 | Film No.: 251446528
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)